Like the rest of the country, distribution of the Johnson and Johnson COVID-19 vaccine is on pause as the CDC and FDA look into reports that a handful of recipients developed blood clots. That revelation kicked off our discussion with Joshua LaBaer, executive director of Arizona State University’s Biodesign Institute. LaBaer also discussed the institute’s recent discovery of a variant of the disease that developed in the state and the ongoing spread of the variant that emerged from the United Kingdom.
Arizona 360 airs Fridays at 8:30 p.m. on PBS 6 and Saturdays at 8 p.m. on PBS 6 PLUS. See more from Arizona 360.
By submitting your comments, you hereby give AZPM the right to post your comments and potentially use them in any other form of media operated by this institution.